Edit |   |
---|---|
Antigenic Specificity | Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4) |
Clone | monoclonal |
Host Species | Mouse |
Reactive Species | human |
Isotype | IgG2a |
Format | Protein G purified |
Size | 80 µl, 400 µl, |
Concentration | n/a |
Applications | ELISA, WB, IHC, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr-185', and of AKT1 at 'Ser-473'. |
Immunogen | Purified His-tagged Human VEGFR3 protein |
Other Names | flt 4, FLT-4, FLT4, FLT41, Fms related tyrosine kinase 4, Fms-like tyrosine kinase 4, fms-related tyrosine kinase 4, LMPH1A, PCL, Soluble VEGFR3 variant 1, Soluble VEGFR3 variant 2, Soluble VEGFR3 variant 3, Tyrosine protein kinase receptor FLT4, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, Vascular endothelial growth factor receptor 3 precursor, VEGF R3, VEGFR 3, VEGFR-3, VEGFR3, flt 4, flt 4, flt 4 , flt 4 , FLT-4, FLT-4, FLT-4 , FLT-4 , FLT4, FLT4, FLT4 , FLT4 , FLT41, FLT41, FLT41 , FLT41 , Fms related tyrosine kinase 4, Fms related tyrosine kinase 4, Fms related tyrosine kinase 4 , Fms related tyrosine kinase 4 , Fms-like tyrosine kinase 4, Fms-like tyrosine kinase 4, Fms-like tyrosine kinase 4 , Fms-like tyrosine kinase 4 , fms-related tyrosine kinase 4, fms-related tyrosine kinase 4, fms-related tyrosine kinase 4 , fms-related tyrosine kinase 4 , LMPH1A, LMPH1A, LMPH1A , LMPH1A , PCL, PCL, PCL , PCL , Soluble VEGFR3 variant 1, S |
Gene, Accession # | NCBI: NP_002011.2, NP_891555.2, UniProt: P35916 |
Catalog # | abx034933 |
Price | please inquire |
Order / More Info | Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950